The role of ATR in preventing age-related diseases

ATR 在预防年龄相关疾病中的作用

基本信息

  • 批准号:
    7456340
  • 负责人:
  • 金额:
    $ 26.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-15 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A gradual loss of genomic integrity has long been proposed to contribute to the aging process. Consistent with this theory, mutation of genes involved in maintaining genome integrity often leads to premature aging. Identifying the potential genetic predispositions to age-related diseases and, more importantly, understanding how these genetic determinants lead to disease will likely guide our ability to better predict, diagnose and slow the onset of these disorders. The ATR protein kinase maintains genome integrity in mammalian cells and is a central regulator of cell cycle checkpoints. Using a cre/lox system that allows conditional deletion of the ATR gene in 2-3 month old adult mice, our preliminary work has demonstrated that several age-related phenotypes appear 3-6 months after ATR deletion. These aging phenotypes include alopecia, hair graying, kyphosis, osteoporosis, cardiomyopathy, testicular atrophy and acute immune suppression. With this unique mouse model, we propose herein to substantiate these initial findings and further explore the role of ATR in preventing age-related diseases. Experiments are proposed to further explore the effect of ATR loss on several disorders that are components of human aging (hair loss and graying, osteoporosis and reduced hematopoietic regenerative capacity) and, importantly, to address if these phenotypes are caused by a loss of regenerative capacity following ATR deletion and/or a direct effect on differentiated cells. To determine if activation of the p53 transcription factor plays a causative role in age-related phenotypes that result from ATR deletion, the premature aging observed in ATR mice will be compared with that observed in mice that lack both ATR and p53. Finally, experiments are proposed that will determine whether the oxidative DNA base damage that results from normal metabolic processes is exacerbated by ATR loss, leading to highly toxic DNA double strand breaks. Such amplification of DNA damage may accelerate normal aging. To test this hypothesis, oxidative DNA damage will be reduced or increased by treatments that modulate intracellular hydroxyl radical concentrations in ATR knockout cells, and the effect of these treatments will be monitored by chromosome spread analysis. These studies will seek a molecular understanding of how ATR deletion leads to premature aging.
描述(由申请人提供):长期以来,已经提出了基因组完整性的逐渐丧失来促进衰老过程。与该理论一致,涉及维持基因组完整性的基因突变通常会导致过早衰老。确定对年龄相关疾病的潜在遗传倾向,更重要的是,了解这些遗传决定因素如何导致疾病如何指导我们更好地预测,诊断和减慢这些疾病的发作的能力。 ATR蛋白激酶在哺乳动物细胞中保持基因组完整性,是细胞周期检查点的中心调节剂。使用CRE/LOX系统,该系统允许在2-3个月大的成年小鼠中有条件地删除ATR基因,我们的初步工作表明,ATR删除后3-6个月出现了几种与年龄相关的表型。这些衰老的表型包括脱发,头发灰色,脑膜病,骨质疏松症,心肌病,睾丸萎缩和急性免疫抑制。借助这种独特的小鼠模型,我们建议在本文中证实这些初始发现,并进一步探讨ATR在预防与年龄有关的疾病中的作用。提出了实验以进一步探索ATR损失对几种疾病的影响,这些疾病是人类衰老的成分(脱发和灰色,骨质疏松症以及造血再生能力的降低),并且重要的是,是否是由ATRETENED DEDETION和/或直接效果的再生能力引起的,以解决这些表型是否引起。为了确定p53转录因子的激活是否在ATR缺失引起的年龄相关表型中起因作用,将在ATR小鼠中观察到的过早衰老与缺乏ATR和p53的小鼠中观察到的过早衰老。最后,提出了实验,该实验将确定是否因ATR损失而加剧了由正常代谢过程导致的氧化DNA碱基损伤,从而导致剧毒DNA双链断裂。 DNA损伤的这种扩增可能会加速正常衰老。为了检验这一假设,通过调节细胞内羟基自由基浓度在ATR基因敲除细胞中的治疗方法将减少或增加氧化性DNA损伤,这些治疗的效果将通过染色体扩散分析来监测。这些研究将寻求分子理解ATR缺失如何导致过早衰老。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric J Brown其他文献

Eric J Brown的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric J Brown', 18)}}的其他基金

Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous ovarian cancer
开发用于治疗高级别浆液性卵巢癌的一流 DNA 损伤反应抑制剂组合
  • 批准号:
    10603092
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
Effect of DNA repeat silencing on efficacy of ATRi in prostate cancer treatment
DNA重复序列沉默对ATRi治疗前列腺癌疗效的影响
  • 批准号:
    10658509
  • 财政年份:
    2023
  • 资助金额:
    $ 26.98万
  • 项目类别:
A novel protein quality control system and its role in tumorigenesis
一种新型蛋白质质量控​​制系统及其在肿瘤发生中的作用
  • 批准号:
    10088426
  • 财政年份:
    2020
  • 资助金额:
    $ 26.98万
  • 项目类别:
Role of Daxx in protein folding and tumorigenesis
Daxx 在蛋白质折叠和肿瘤发生中的作用
  • 批准号:
    10249990
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
Highly specific ATR inhibitors for the targeted treatment of a broad spectrum of cancers
高度特异性的 ATR 抑制剂,用于多种癌症的靶向治疗
  • 批准号:
    9202326
  • 财政年份:
    2016
  • 资助金额:
    $ 26.98万
  • 项目类别:
Effects of ATR-CHK1 inhibition on genome stability and cancer progression
ATR-CHK1 抑制对基因组稳定性和癌症进展的影响
  • 批准号:
    9042322
  • 财政年份:
    2015
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7907272
  • 财政年份:
    2009
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7022098
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    8677675
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7259328
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:

相似海外基金

Protein Phosphatase PP2A and DNA damage in cell fate decisions of acute myeloid leukemic cells
蛋白磷酸酶 PP2A 和 DNA 损伤在急性髓系白血病细胞命运决定中的作用
  • 批准号:
    10019487
  • 财政年份:
    2019
  • 资助金额:
    $ 26.98万
  • 项目类别:
Highly specific ATR inhibitors for the targeted treatment of a broad spectrum of cancers
高度特异性的 ATR 抑制剂,用于多种癌症的靶向治疗
  • 批准号:
    9202326
  • 财政年份:
    2016
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7907272
  • 财政年份:
    2009
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7259328
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7882276
  • 财政年份:
    2006
  • 资助金额:
    $ 26.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了